Expression profile of MicroRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus

Annals of Surgery

Volumn 259, Issue 2, 2014, Pages 346-354

  Yeh, Ta Sen ^a   Wang, Frank ^a   Chen, Tse Ching ^a   Yeh, Chun Nan ^a   Yu, Ming Chin ^a   Jan, Yi Yin ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

epithelial to mesenchymal transition; hepatocellular carcinoma with bile duct tumor thrombosis; microRNA 200 family

Indexed keywords

BMI1 PROTEIN; INTERLEUKIN 6; MICRORNA 141; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 429; SOMATOMEDIN BINDING PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; BILE DUCT TUMOR; CANCER CELL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LONG TERM SURVIVAL; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR THROMBUS;

EID: 84892945531     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000223     Document Type: Article

References (41)

1. Cheng CH, Lee CF,Wu TH, et al. Evaluation of the new AJCC staging system for respectable hepatocellular carcinoma. World J Surg Oncol. 2011;9:114.
2. Lin TY, Chen KM, Chen YR, et al. Icteric type hepatoma. Med Chir Dig. 1975;4:267-270.
3. Tantawi B, Cherqui D, Tran van Nhieu J, et al. Surgery for biliary obstruction by tumor thrombus in primary liver cancer. Br J Surg. 1996;83:1522-1525.
4. Yeh CN, Jan YY, Lee WC, et al. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg. 2004;28:471-474.
5. Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepato-cellular carcinoma with bile duct thrombi. Surgery. 2000;127:779-783.
6. Yu XH, Xu L, Liu C, et al. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. Dig Dis Sci. 2011;56:252-259.
7. Long XY, Li YX, Wu W, et al. Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass. World J Gastroenterol. 2010;16:4998-5004.
8. Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery. 2001;129:692-698.
9. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SP1. Nat Cell Biol Cell Biol. 2008;10:593-601.
10. Park SM, Gaur AB, Lengyel E, et al. The miR200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Gene Dev. 2008;22:894-907.
11. Gao ZH, Tretiakova MS, Liu WH, et al. Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Modern Pathol. 2006;19: 533-540.
12. Salahshor S, Naidoo R, Serra S, et al. Frequent accumulation of nuclear Ecadherin and alterations in theWnt signaling pathway in esophageal squamous cell carcinomas. Modern Pathol. 2008;21:271-281.
13. Yu J, Ohuchida K, Mizumoto K, et al. MicroRNA, has-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer. 2010;9: 169.
14. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-to mesenchymal transition and cancer metastasis. RNA Biol. 2008;5:115-119.
15. Snowdon J, ZhangX, Childs T, et al. ThemicroRNA-200 family is upregulated in endometrial carcinoma. PLoS One. 2011;6:e22828.
16. Chen J, Wang L, Matyunina LV, et al. Overexpression of miR429-induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecologic Oncol. 2011;121:200-205.
17. Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelialto-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res. 2009;15:5060-5072.
18. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25:2537-2545.
19. Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocellular carcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50:490-499.
20. Yao J, Liang L, Huang S, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010;51:846-856.
21. Liu S, Guo W, Shi J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol. 2012;56:389-396.
22. Law PTY,Wong N. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:437-450.
23. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelialmesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910-14914.
24. Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nature Rev. 2002;2:442-454.
25. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006;12:5369-5376.
26. Miyoshi A, Kitajima Y, Kido S, et al. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer. 2005;92:252-258.
27. Sugimachi K, Tanaka S, Kameyama T, et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res. 2003;9:2657-2664.
28. Yang MH, Chen CL, Chau GY, et al. Comprehensive analysis of the independent effect of Twist and Snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009;50:1464-1474.
29. Giannelli G, Bergamini C, Fransvea E, et al. Laminin-5 with transforming growth factor-β1 induces epithelial tomesenchymal transition in hepatocellular carcinoma. Gastroenterol. 2005;129:1375-1383.
30. Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197-208.
31. Rokavec M, Wu W, Luo JL. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit during transformation and tumorigenesis. Mol Cell. 2012;45:777-789.
32. Chang CJ, Chao CH, Xia W, et al. P53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011;13:317-323.
33. Kim T, Veronese A, Pichiorri F, et al. p53 regulates epithelial- mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011;208:875-883.
34. Knouf EC, Garg K, Arroyo JD, et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res. 2012;40:499-510.
35. Concin N, Becker K, Slade N, et al. Transdominant Delta Tap73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res. 2004;64:2449-2460.
36. Ibrahim N, He L, Leong CO, et al. BRAC-1-Associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma. Cancer Res. 2010;70:7155-7165.
37. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-715.
38. Brabletz T, Jung A, Spaderna S, et al. Migrating cancer stem cells-An integrated concept of malignant tumor progression. Nat Rev Cancer. 2005;5:744-749.
39. Yi R, Roy MN, Stoffel M, et al. A skin microRNA promotes differentiation by repressing "stemness." Nature. 2008;452:225-229.
40. Wellner U, Schubert J, Burk UC, et al. The EMT-Activator ZEB1 promotes tumorigenecity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11:1487-1495.
41. Korpal M, Ell BJ, Buffa FM, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature Med. 2011;17:1101-1108.